194 related articles for article (PubMed ID: 22615544)
1. Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system?
Moon S; Bermudez J; 't Hoen E
PLoS Med; 2012; 9(5):e1001218. PubMed ID: 22615544
[TBL] [Abstract][Full Text] [Related]
2. [An alternative and innovative Research and Development model to ensure access to medicines - Neglected diseases, neglected populations, and biomedical innovation system].
Pécoul B
Med Sci (Paris); 2016 Dec; 32(12):1049-1050. PubMed ID: 28044961
[No Abstract] [Full Text] [Related]
3. Privatized Pharmaceutical Innovation vs Access to Essential Medicines: A Global Framework for Equitable Sharing of Benefits.
Burci GL; Gostin LO
JAMA; 2017 Feb; 317(5):473-474. PubMed ID: 28170485
[No Abstract] [Full Text] [Related]
4. More medicines alone cannot ensure the treatment of neglected tropical diseases.
Chami GF; Bundy DAP
Lancet Infect Dis; 2019 Sep; 19(9):e330-e336. PubMed ID: 31160190
[TBL] [Abstract][Full Text] [Related]
5. Linking research to global health equity: the contribution of product development partnerships to access to medicines and research capacity building.
Pratt B; Loff B
Am J Public Health; 2013 Nov; 103(11):1968-78. PubMed ID: 24028246
[TBL] [Abstract][Full Text] [Related]
6. The courage to change the rules: a proposal for an essential health R&D treaty.
Dentico N; Ford N
PLoS Med; 2005 Feb; 2(2):e14. PubMed ID: 15736991
[TBL] [Abstract][Full Text] [Related]
7. Powerful Ideas for Global Access to Medicines.
Moon S
N Engl J Med; 2017 Feb; 376(6):505-507. PubMed ID: 28099819
[No Abstract] [Full Text] [Related]
8. Global health: neglected diseases and access to medicines.
Garg NJ
Infect Dis Clin North Am; 2011 Sep; 25(3):639-51, ix-x. PubMed ID: 21896364
[TBL] [Abstract][Full Text] [Related]
9. Expert Delphi survey on research and development into drugs for neglected diseases.
Fehr A; Thürmann P; Razum O
BMC Health Serv Res; 2011 Nov; 11():312. PubMed ID: 22087801
[TBL] [Abstract][Full Text] [Related]
10. Assessing 15 proposals for promoting innovation and access to medicines globally.
Hoffman SJ; So K;
Ann Glob Health; 2014; 80(6):432-43. PubMed ID: 25960092
[TBL] [Abstract][Full Text] [Related]
11. [Industry, Academia and Government Partnership through the Global Health Innovative Technology Fund (GHIT)].
Hinoshita E
Yakugaku Zasshi; 2016; 136(2):237-42. PubMed ID: 26831799
[TBL] [Abstract][Full Text] [Related]
12. [Partnership Activity for Neglected Tropical Diseases].
Akao Y; Ochida A; Muranishi H; Nomura I; Ichikawa T
Yakugaku Zasshi; 2022; 142(7):697-701. PubMed ID: 35781496
[TBL] [Abstract][Full Text] [Related]
13. First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium.
Musselwhite LW; Maciag K; Lankowski A; Gretes MC; Wellems TE; Tavera G; Goulding RE; Guillen E
Am J Trop Med Hyg; 2012 Jan; 86(1):65-74. PubMed ID: 22232453
[TBL] [Abstract][Full Text] [Related]
14. [Management of neglected diseases: efficacy of an innovative approach].
Pécoul B
Rev Med Suisse; 2011 Apr; 7(292):928-9. PubMed ID: 21674898
[No Abstract] [Full Text] [Related]
15. The Health Impact Fund: a potential solution to inequity in global drug access.
Banerjee A; Pogge T
Indian J Med Ethics; 2010; 7(4):240-3. PubMed ID: 22106579
[TBL] [Abstract][Full Text] [Related]
16. Fostering innovative product development for neglected tropical diseases through partnerships.
Starr A; Graef KM; Dent J
Pharm Pat Anal; 2016 Sep; 5(6):391-400. PubMed ID: 27813447
[TBL] [Abstract][Full Text] [Related]
17. [Alternatives to the drug research and development model].
Velásquez G
Salud Colect; 2015 Mar; 11(1):23-34. PubMed ID: 25853828
[TBL] [Abstract][Full Text] [Related]
18. Needs-driven versus market-driven pharmaceutical innovation: the consortium for the development of a new medicine against malaria in Brazil.
Kameda K
Dev World Bioeth; 2014 Aug; 14(2):101-8. PubMed ID: 24761744
[TBL] [Abstract][Full Text] [Related]
19. [International Partnership for Therapeutic Drug Development of NTDs by DNDi].
Yamada H; Hirabayashi F; Brünger C
Yakugaku Zasshi; 2016; 136(2):213-22. PubMed ID: 26831796
[TBL] [Abstract][Full Text] [Related]
20. From recipe to research: introducing undergraduate students to the nature of science using a hybrid practical course centred on drug discovery for neglected diseases.
Wijtmans M; Edink E; van Linden OP; Zheng Y; Blaazer AR; Siderius M; van Muijlwijk-Koezen JE
Drug Discov Today; 2021 Jun; 26(6):1359-1368. PubMed ID: 33609778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
